Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Type 2 diabetes mellitus--guidelines for initiating insulin therapy Yeap BBAust Fam Physician 2007[Jul]; 36 (7): 549-53BACKGROUND: Insulin is often indicated for patients with suboptimally controlled type 2 diabetes mellitus, despite lifestyle modification and oral antidiabetic agents. OBJECTIVE: This article outlines the initiation of insulin therapy for patients with type 2 diabetes in the general practice context. DISCUSSION: Insulin initiation options are bed time basal insulin (NPH, glargine) 10 U for patients with fasting hyperglycaemia, or twice daily premixed insulin (eg. aspart 30%/NPH 70%) 6-10 U twice per day targeting day time or postprandial hyperglycaemia. Basal insulin should be titrated regularly on a prophylactic basis (eg. fasting glucose <4.4 mmol/L: -2U, 4.4-7.0: +0 U, 7.1-10.0: +2 U, >10.0: +4 U) or increased by 1 U/day until fasting glucose of 5.5 mmol/L is reached. HbA1c changes of -1.5 to -2.5% are achievable with potential weight gain around 3 kg over 6 months. Approximately 50% of patients can achieve HbA1c or=9.5% insulin results in greater improvement in fasting glucose and HbA1c. Patients require education for blood glucose monitoring, healthy diet, exercise and identifying and responding to hypoglycaemia.|Adult[MESH]|Aged[MESH]|Blood Glucose/*drug effects[MESH]|Diabetes Mellitus, Type 2/*drug therapy[MESH]|Drug Administration Schedule[MESH]|Humans[MESH]|Hypoglycemic Agents/*administration & dosage/therapeutic use[MESH]|Insulin/*administration & dosage/therapeutic use[MESH]|Middle Aged[MESH]|Practice Guidelines as Topic[MESH] |